QLINEA Profitability Analysis: Past Growth, Margins, Return on Capital, Free Cash Flow, and more - Q linea AB - Alpha Spread

Q linea AB
STO:QLINEA

Watchlist Manager
Q linea AB Logo
Q linea AB
STO:QLINEA
Watchlist
Price: 2.98 SEK -3.56%
Market Cap: 348.2m SEK
Have any thoughts about
Q linea AB?
Write Note

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Q linea AB

Revenue
4.7m SEK
Cost of Revenue
-7.3m SEK
Gross Profit
-2.6m SEK
Operating Expenses
-222.3m SEK
Operating Income
-225m SEK
Other Expenses
365k SEK
Net Income
-224.6m SEK

Margins Comparison
Q linea AB Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
SE
Q linea AB
STO:QLINEA
352.1m SEK
-56%
-4 792%
-4 784%
US
Abbott Laboratories
NYSE:ABT
198.5B USD
55%
17%
14%
US
Intuitive Surgical Inc
NASDAQ:ISRG
173.7B USD
67%
26%
28%
US
Stryker Corp
NYSE:SYK
138.8B USD
64%
22%
16%
US
Boston Scientific Corp
NYSE:BSX
124B USD
69%
18%
12%
IE
Medtronic PLC
NYSE:MDT
114.6B USD
66%
19%
12%
US
Becton Dickinson and Co
NYSE:BDX
67.7B USD
45%
15%
7%
DE
Siemens Healthineers AG
XETRA:SHL
55.7B EUR
38%
12%
8%
US
IDEXX Laboratories Inc
NASDAQ:IDXX
42.9B USD
60%
29%
22%
US
Edwards Lifesciences Corp
NYSE:EW
40.8B USD
77%
28%
25%
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
41.3B USD
41%
13%
8%
Country SE
Market Cap 352.1m SEK
Gross Margin
-56%
Operating Margin
-4 792%
Net Margin
-4 784%
Country US
Market Cap 198.5B USD
Gross Margin
55%
Operating Margin
17%
Net Margin
14%
Country US
Market Cap 173.7B USD
Gross Margin
67%
Operating Margin
26%
Net Margin
28%
Country US
Market Cap 138.8B USD
Gross Margin
64%
Operating Margin
22%
Net Margin
16%
Country US
Market Cap 124B USD
Gross Margin
69%
Operating Margin
18%
Net Margin
12%
Country IE
Market Cap 114.6B USD
Gross Margin
66%
Operating Margin
19%
Net Margin
12%
Country US
Market Cap 67.7B USD
Gross Margin
45%
Operating Margin
15%
Net Margin
7%
Country DE
Market Cap 55.7B EUR
Gross Margin
38%
Operating Margin
12%
Net Margin
8%
Country US
Market Cap 42.9B USD
Gross Margin
60%
Operating Margin
29%
Net Margin
22%
Country US
Market Cap 40.8B USD
Gross Margin
77%
Operating Margin
28%
Net Margin
25%
Country US
Market Cap 41.3B USD
Gross Margin
41%
Operating Margin
13%
Net Margin
8%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Q linea AB Competitors

Country Company Market Cap ROE ROA ROCE ROIC
SE
Q linea AB
STO:QLINEA
352.1m SEK
-445%
-133%
-358%
-163%
US
Abbott Laboratories
NYSE:ABT
198.5B USD
15%
8%
11%
9%
US
Intuitive Surgical Inc
NASDAQ:ISRG
173.7B USD
16%
14%
14%
19%
US
Stryker Corp
NYSE:SYK
138.8B USD
19%
9%
15%
11%
US
Boston Scientific Corp
NYSE:BSX
124B USD
9%
5%
9%
7%
IE
Medtronic PLC
NYSE:MDT
114.6B USD
8%
4%
8%
6%
US
Becton Dickinson and Co
NYSE:BDX
67.7B USD
5%
3%
6%
6%
DE
Siemens Healthineers AG
XETRA:SHL
55.7B EUR
11%
4%
8%
5%
US
IDEXX Laboratories Inc
NASDAQ:IDXX
42.9B USD
63%
27%
51%
31%
US
Edwards Lifesciences Corp
NYSE:EW
40.8B USD
21%
15%
20%
21%
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
41.3B USD
21%
5%
10%
6%
Country SE
Market Cap 352.1m SEK
ROE
-445%
ROA
-133%
ROCE
-358%
ROIC
-163%
Country US
Market Cap 198.5B USD
ROE
15%
ROA
8%
ROCE
11%
ROIC
9%
Country US
Market Cap 173.7B USD
ROE
16%
ROA
14%
ROCE
14%
ROIC
19%
Country US
Market Cap 138.8B USD
ROE
19%
ROA
9%
ROCE
15%
ROIC
11%
Country US
Market Cap 124B USD
ROE
9%
ROA
5%
ROCE
9%
ROIC
7%
Country IE
Market Cap 114.6B USD
ROE
8%
ROA
4%
ROCE
8%
ROIC
6%
Country US
Market Cap 67.7B USD
ROE
5%
ROA
3%
ROCE
6%
ROIC
6%
Country DE
Market Cap 55.7B EUR
ROE
11%
ROA
4%
ROCE
8%
ROIC
5%
Country US
Market Cap 42.9B USD
ROE
63%
ROA
27%
ROCE
51%
ROIC
31%
Country US
Market Cap 40.8B USD
ROE
21%
ROA
15%
ROCE
20%
ROIC
21%
Country US
Market Cap 41.3B USD
ROE
21%
ROA
5%
ROCE
10%
ROIC
6%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top